Employees Provident Fund Board’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$622M Sell
518,259
-6,102
-1% -$6.23M 3.57% 8
2026
Q1
$482M Buy
524,361
+207,268
+65% +$210M 3.64% 6
2025
Q4
$341M Sell
317,093
-304,742
-49% -$291M 2.5% 11
2025
Q3
$474M Buy
621,835
+68,960
+12% +$51.3M 3.81% 5
2025
Q2
$431M Buy
552,875
+162,894
+42% +$127M 3.73% 5
2025
Q1
$322M Buy
389,981
+117,356
+43% +$97.7M 3.66% 4
2024
Q4
$210M Buy
272,625
+129,698
+91% +$107M 2.61% 7
2024
Q3
$127M Sell
142,927
-12,421
-8% -$11.2M 1.73% 15
2024
Q2
$141M Buy
155,348
+118,548
+322% +$94.8M 2.25% 11
2024
Q1
$28.6M Sell
36,800
-1,140
-3% -$811K 0.5% 51
2023
Q4
$22.1M Sell
37,940
-97,634
-72% -$57M 0.43% 49
2023
Q3
$72.8M Buy
135,574
+91,897
+210% +$47.4M 1.65% 25
2023
Q2
$20.5M Buy
43,677
+25,240
+137% +$10.6M 0.49% 51
2023
Q1
$6.33M Buy
+18,437
New +$6.22M 0.16% 65

Other funds holding LLY

Employees Provident Fund Board's LLY Position: Q2 2026 in Review

Employees Provident Fund Board reduced its Eli Lilly (LLY) stake by 1.2% in Q2 2026, selling an estimated $6.23M and leaving 518,259 shares worth $622M. The position accounts for 3.57% of the portfolio, ranked #8.

Employees Provident Fund Board first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 4,593 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Employees Provident Fund Board held 518,259 shares of Eli Lilly worth $622M as of Q2 2026.
  • Employees Provident Fund Board sold 6,102 Eli Lilly shares in Q2 2026, an estimated $6.23M.
  • Eli Lilly made up 3.57% of Employees Provident Fund Board's portfolio in Q2 2026, its #8 holding.
  • Employees Provident Fund Board first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 4,593 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Employees Provident Fund Board's 13F filing for Q2 2026, filed 12 Aug 2026.